APTEEUS is innovating in the field of individualized medicine by developing treatments for patients with rare and orphan diseases.
APTEEUS involves the patient and his medical doctor in the discovery of a treatment and the individualized repositioning of a drug.
We have developed an innovative technology that is able to test all available active pharmaceutical ingredients in the world directly on patient cells. That technology helps in identifying a therapeutic outcome for patients suffering from orphan diseases. The individual benefit is immediate and it is often the starting point of a new clinical and pharmaceutical development in the new indication for the population of patients concerned.
This innovative process progressively engages patients in the development of the drug on the basis of the response of their cells to treatment. The repositioning of the drug resulting is less risky, less expensive and faster than the development of new molecules. We best respond to medical need in the field of rare and orphan diseases, taking into account the individuality of each.
The first edition of Hibster is 120 brains in turmoil, 48h of thinking for unlimited creativity. One team will work on individualized medicine proposed by APTEEUS. Eager to see the result!Read More
This is thanks to an innovative strategy of Individualized Medicine, that the pair of Pharmacists, Terence Beghyn and Benoit Deprez were awarded at the Concours Mondial de l’Innovation in the category “Individualized Medicine” the 18th…Read More
2016 APTEΞUS team wishes you happy holidays and successful New Year.Read More